RHYTHM PHARMACEUTICALS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+22.4% +$88M
$480M
Current Assets↑+24.8% +$93M
$467M
Cash & Equivalents↓-39.1% -$35M
$54M
ST Investments↑+44.6% +$103M
$335M
Receivables↑+40.9% +$8M
$26M
Inventory↑+37.4% +$7M
$26M
Net PPE↑+74.7% +$472K
$1M
Intangibles↓-13.8% -$855K
$5M
Total Liabilities↓-7.7% -$18M
$210M
Current Liabilities↓-8.3% -$10M
$106M
Account Payables↑+13.1% +$2M
$14M
Long-Term Debt↓-6.8% -$7M
$101M
Stockholders Equity↑+540.0% +$117M
$139M
Retained Earnings↓-17.0% -$197M
$-1.35B
Operating Lease ROU Asset↓-12.3% -$428K
$3M
Operating Lease Liability↓-15.1% -$596K
$3M
Gross PP&E↑+17.7% +$954K
$6M
Accumulated Depreciation↑+10.1% +$482K
$5M
Inventory Raw Materials↓-0.5% -$31K
$7M
Inventory WIP↑+30.5% +$381K
$2M
Inventory Finished Goods↑+62.2% +$7M
$17M
Total Debt Carrying Amount
—